Application of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction

LU Aifen, ZHU Guijia, FENG Zhikuan, LIU Junyou, ZHANG Ke

PDF(7133 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(7133 KB)
World Clinical Drug ›› 2024, Vol. 45 ›› Issue (12) : 1269-1275. DOI: 10.13683/j.wph.2024.12.009
Article

Application of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 45(12): 1269-1275 https://doi.org/10.13683/j.wph.2024.12.009

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(7133 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉